日本将启用“癌细胞库”加强个性化医疗

2016-11-08 华义 中国科学报

日本将启用“癌细胞库”加强个性化医疗

 

新华社电 日本大阪府立成人病中心日前宣布,将于明年4月起启用一个可以保存癌症患者癌细胞的“癌细胞库”,未来通过与制药公司和研究机构等合作,可将这些保存的癌细胞用于个性化癌症医疗和开发抗癌药。

据介绍,癌细胞的扩散情况和药物疗法都因人而异。要进行个性化医疗,就需要有针对性地研究某名患者个体的癌细胞,但通常手术中切下的癌组织很快就会消亡,难以在实验室中用于药物测试等方面。

这个“癌细胞库”将收集从患者体内切除的癌细胞并进行适当培养,然后利用液氮进行冷冻保存,在需要的时候再解冻,从而能够按需获得“活着的癌细胞”。该中心认为,这可以加强个性化癌症医疗,比如在患者身上使用抗癌剂之前,可对来自患者本人的癌细胞进行药物测试,选择最佳的治疗方案。

该中心说,目前已经保存有50种大肠癌细胞和30种肺癌细胞。随着“癌细胞库”的发展,制药公司和其他研究机构也可以利用保存的癌细胞开发药物。(华义)

《中国科学报》 (2016-11-08 第2版 国际)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1700264, encodeId=015a1e0026414, content=<a href='/topic/show?id=ec08213328c' target=_blank style='color:#2F92EE;'>#个性化医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21332, encryptionId=ec08213328c, topicName=个性化医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16e930021335, createdName=w363522459, createdTime=Thu May 18 05:26:00 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069749, encodeId=d63e2069e4934, content=<a href='/topic/show?id=becde7897ae' target=_blank style='color:#2F92EE;'>#细胞库#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77897, encryptionId=becde7897ae, topicName=细胞库)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sat Jun 24 23:26:00 CST 2017, time=2017-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252153, encodeId=938f1252153b9, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Nov 10 09:26:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294281, encodeId=25911294281e8, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Nov 10 09:26:00 CST 2016, time=2016-11-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1700264, encodeId=015a1e0026414, content=<a href='/topic/show?id=ec08213328c' target=_blank style='color:#2F92EE;'>#个性化医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21332, encryptionId=ec08213328c, topicName=个性化医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16e930021335, createdName=w363522459, createdTime=Thu May 18 05:26:00 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069749, encodeId=d63e2069e4934, content=<a href='/topic/show?id=becde7897ae' target=_blank style='color:#2F92EE;'>#细胞库#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77897, encryptionId=becde7897ae, topicName=细胞库)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sat Jun 24 23:26:00 CST 2017, time=2017-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252153, encodeId=938f1252153b9, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Nov 10 09:26:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294281, encodeId=25911294281e8, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Nov 10 09:26:00 CST 2016, time=2016-11-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1700264, encodeId=015a1e0026414, content=<a href='/topic/show?id=ec08213328c' target=_blank style='color:#2F92EE;'>#个性化医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21332, encryptionId=ec08213328c, topicName=个性化医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16e930021335, createdName=w363522459, createdTime=Thu May 18 05:26:00 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069749, encodeId=d63e2069e4934, content=<a href='/topic/show?id=becde7897ae' target=_blank style='color:#2F92EE;'>#细胞库#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77897, encryptionId=becde7897ae, topicName=细胞库)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sat Jun 24 23:26:00 CST 2017, time=2017-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252153, encodeId=938f1252153b9, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Nov 10 09:26:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294281, encodeId=25911294281e8, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Nov 10 09:26:00 CST 2016, time=2016-11-10, status=1, ipAttribution=)]
    2016-11-10 yxch36
  4. [GetPortalCommentsPageByObjectIdResponse(id=1700264, encodeId=015a1e0026414, content=<a href='/topic/show?id=ec08213328c' target=_blank style='color:#2F92EE;'>#个性化医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21332, encryptionId=ec08213328c, topicName=个性化医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16e930021335, createdName=w363522459, createdTime=Thu May 18 05:26:00 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069749, encodeId=d63e2069e4934, content=<a href='/topic/show?id=becde7897ae' target=_blank style='color:#2F92EE;'>#细胞库#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77897, encryptionId=becde7897ae, topicName=细胞库)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sat Jun 24 23:26:00 CST 2017, time=2017-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252153, encodeId=938f1252153b9, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Nov 10 09:26:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294281, encodeId=25911294281e8, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Nov 10 09:26:00 CST 2016, time=2016-11-10, status=1, ipAttribution=)]

相关资讯

Nature子刊:谁给癌细胞穿上了“隐形衣”?

导语:哈利波特的隐身斗篷是很多人梦寐以求的东西。这件“神器”帮助主人躲过了很多危险。今天,小编要介绍的是癌细胞的“隐身衣”,它也帮助“主人”巧妙的躲过免疫系统的监视,让主人威武壮大。那么,癌细胞的“隐身衣”是什么做的呢?9月13日,发表在Scientific Reports上的一项研究中,英属哥伦比亚大学(University of British Columbia,UBC)的科学家们发现了癌细胞

Science:帮助癌细胞获得“永生”的基因开关被发现

科学家们最近发现一个参与DNA包装的基因开关可能是癌细胞获得永生能力的关键。相关研究结果发表在国际学术期刊Science上。弗朗西斯克里克研究所的研究人员在Cancer Research UK的部分资助下发现一种叫做H1.0的蛋白表达在许多癌症类型中经常发生关闭,重新激活这种蛋白的表达能够阻止肿瘤的生长。通过对缺少H1.0的癌细胞进行研究,他们发现DNA在一些关键位置处于展开状态,导致一系列基因发

Nature:好“邻居”如何“喂养”癌细胞?

癌细胞为了生存可谓是“绞尽脑汁”。8月10日,发表在Nature上的一项研究发现,在胰腺癌中,邻近的非癌细胞能够通过自噬过程降解自身的蛋白质,释放一种氨基酸供癌细胞使用。那么,这个“好邻居”是谁?癌细胞又是如何从“好邻居”巧借“粮食”的呢?

Cancer Cell:CD98——打破白血病癌细胞支持性微环境的新靶点

急性髓性白血病(AML)是一类侵染力较强的癌症,由于骨髓生成血细胞的过程发生异常所致,常常出现复发和和抗药性。最近,加州大学圣地亚哥分校(UCSD)的研究者们发现,AML癌细胞表达的一种细胞表面蛋白CD98具有促进癌变的作用,而CD98的抗体IGN523则能够遏制AML癌细胞在体外和小鼠体内的生长。这一成果发表于近期的Cell子刊《Cancer Cell》上。“要想对该病的疗法进行改进,我们不仅需

重大突破:癌细胞“逆发育”成正常细胞

导语:梅奥诊断的科学家们发现了让癌细胞实现“逆生长”回到正常细胞的方法。主要研究人员表示,这为关闭癌症系统提供了新的“代码”。发表在Nature Cell Biology杂志上的一项研究中,梅奥诊断的科学家们发现了让癌细胞实现“逆生长”回到正常细胞的方法。主要研究人员Panos Anastasiadis博士表示,这为关闭癌症系统提供了新的“代码”,而这个代码的发现与miRNAs相关。据世界卫生组织

Dev Cell:癌细胞也会患阿尔兹海默氏症!或点亮癌症新疗法

近日,来自迈阿密大学米勒医学院的研究人员通过研究发现,在癌症进展及转移过程中扮演重要角色的特定蛋白质能够在休眠的癌细胞中以淀粉样体(Amyloid bodies)的形式储存,一旦淀粉样体分解,癌细胞就会再度活化,相关研究刊登于国际杂志Developmental Cell上。 淀粉样体被认为在神经性疾病的发生过程中扮演着重要角色,比如阿尔兹海默氏症和帕金森疾病等,但淀粉样体在癌